News
Vanda Pharma: Q4 Earnings Insights
7 Feb 24
Earnings
Vanda Pharma Q4 2023 GAAP EPS $(0.04) Beats $(0.09) Estimate, Sales $45.27M Beat $37.00M Estimate
7 Feb 24
Earnings, Earnings Beats, News
Earnings Scheduled For February 7, 2024
7 Feb 24
Earnings
Earnings Preview For Vanda Pharma
6 Feb 24
Earnings
Vanda Pharmaceuticals Announces FDA Update For Supplemental NDA For HETLIOZ
5 Feb 24
Biotech, News, FDA, General
Court Orders FDA To Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request By March 5, 2024
30 Jan 24
News, FDA, Legal
Vanda Pharmaceuticals Announced Court Granted Vanda's Motion For Summary Judgment On Its Claim Against The FDA
29 Jan 24
News, FDA, Legal
Vanda Pharmaceuticals Receives U.S. Patent Allowance For PONVORY® (Ponesimod) In The U.S.
26 Jan 24
News
Vanda Pharmaceuticals Announces The U.S. Patent And Trademark Office Issued A Notice Of Allowance For PONVORY #17/962,968, Covering Methods For Reducing Clinical Management Events Before Or During The Treatment Of MS And Methods For Reinitiating Treatment After Missed Doses
25 Jan 24
Biotech, News, General
Vanda Pharmaceuticals Announces Publication Of An Article On "The Efficacy Of Tradipitant In Patients With Diabetic And Idiopathic Gastroparesis In Phase III Randomized Placebo-Controlled Clinical Trial" In The Clinical Gastroenterology And Hepatology
25 Jan 24
Biotech, News, General
12 Health Care Stocks Moving In Friday's After-Market Session
19 Jan 24
Movers
Federal Court Allows Vanda Pharmaceuticals' Lawsuit To Proceed Against The U.S. Food And Drug Administration
19 Jan 24
Biotech, News, FDA, Legal, General
Vanda Pharmaceuticals Announces The Publication Of Efficacy And Safety Of Iloperidone In Bipolar Mania: A Double-Blind, Placebo-Controlled Study In The Journal Of Clinical Psychiatry; Findings Of Study Have Been Submitted To The U.S. FDA
17 Jan 24
Biotech, News, FDA, General
Vanda Pharmaceuticals Responds To Recent FDA Guidance
12 Jan 24
News, FDA
Press releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA
27 Mar 24
Press Releases
Thinking about buying stock in Intellicheck, Vanda Pharmaceuticals, Dave Inc, Invivyd, or Dream Finders Homes?
25 Mar 24
Opinion, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA
23 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA
19 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA
15 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA
11 Mar 24
Press Releases
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia
6 Mar 24
Press Releases
Thinking about buying stock in Maravai Lifesciences, Abercrombie & Fitch, elf Beauty, IONQ, or Vanda Pharmaceuticals?
23 Feb 24
Opinion, Press Releases
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
7 Feb 24
Earnings, Press Releases
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia
5 Feb 24
Press Releases
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024
31 Jan 24
Press Releases
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis
31 Jan 24
Press Releases
Court Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request by March 5, 2024
30 Jan 24
Press Releases
Court Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request by March 5, 2024
29 Jan 24
Press Releases
Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.
25 Jan 24
Press Releases
Vanda Pharmaceuticals announces the publication of an article on "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial" in the Clinical Gastroenterology and Hepatology Journal
25 Jan 24
Press Releases
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
23 Jan 24
Press Releases
Federal Court Allows Vanda Pharmaceuticals' Lawsuit to Proceed Against the U.S. Food and Drug Administration
19 Jan 24
Press Releases
Vanda Pharmaceuticals announces the publication of Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study in the Journal of Clinical Psychiatry
17 Jan 24
Press Releases
Vanda Pharmaceuticals Comments on FDA's Recently Announced Guidance on Communication with Health Care Professionals Regarding FDA-Approved Drugs
12 Jan 24
Press Releases